Skip to content

Comparison of the effects of remazolam tosylate and etomidate on the hemodynamics of non-cardiac surgery induced general anesthesia in elderly patients with hypertension: a randomized, double-blind, controlled trail

Comparison of the effects of remazolam tosylate and etomidate on the hemodynamics of non-cardiac surgery induced general anesthesia in elderly patients with hypertension: a randomized, double-blind, controlled trail

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064997
Enrollment
Unknown
Registered
2022-10-25
Start date
2022-10-28
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension in the elderly patients

Interventions

group 2:Low-dose remimazolam tosylate for injection
group 3:High dose remimazolam tosylate for injection

Sponsors

Affiliated Hospital of Guizhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Elderly hypertensive patients who plan to undergo elective non-cardiac surgery; 2. Age > 65 years old, ASA I-? level; 3. Clearly understand and voluntarily participate in the study, and the informed consent is signed by himself or his family members.

Exclusion criteria

Exclusion criteria: 1. Patients who are allergic to benzodiazepines, etomidate, opioids and their ingredients or have contraindications; 2. Patients with obvious respiratory dysfunction before operation (obstructive sleep apnea syndrome, acute respiratory infection, acute exacerbation of chronic obstructive pulmonary disease, uncontrolled asthma, etc.); 3. Those with preoperative circulatory dysfunction (unstable angina pectoris; myocardial infarction within 6 months before screening; resting ECG heart rate = 450 ms, female >= 470 ms); 4. Anemia or thrombocytopenia: Hb < 90 g/L, PLT < 80 × 10^9/L; 5. Suffering from psychiatric diseases (schizophrenia, mania, bipolar disorder, insanity, etc.) and long-term history of taking psychotropic drugs and cognitive dysfunction; 6. Patients who are judged to have difficulties in airway management: modified Matheson score grade III and above; 7. Patients who are participating in other clinical trials; 8. The investigator thinks that it is not suitable to participate in this trial.

Design outcomes

Primary

MeasureTime frame
MAP change value during induction of general anesthesia;HR change value during induction of general anesthesia;Incidence of cardiovascular adverse events;

Secondary

MeasureTime frame
Use of vasoactive drugs;Postoperative cognitive function;

Countries

China

Contacts

Public ContactZou Xiaohua

Affiliated Hospital of Guizhou Medical University

562931613@qq.com+86 13809416036

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026